Logotipo do repositório
 

Publicação:
Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group

dc.contributor.authorGarcia de Carvalho, Natalia Fernandes
dc.contributor.authorSato, Daisy Nakamura
dc.contributor.authorPavan, Fernando R. [UNESP]
dc.contributor.authorFerrazoli, Lucilaine
dc.contributor.authorChimara, Erica
dc.contributor.institutionAdolfo Lutz Inst
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-11-27T22:55:17Z
dc.date.available2018-11-27T22:55:17Z
dc.date.issued2016-09-01
dc.description.abstractBackground: Mycobacterium abscessus group has heterogeneous susceptibility pattern among species. The species is most common cause of nosocomial infections. Macrolides minimum Inhibitory concentration (MIC) determination is essential for the treatment. Methods: Thirty-six strains were randomly selected for performing Resazurin Microtiter Assay (REMA) for clarithromycin testing in comparison to MIC test according to Clinical and Laboratory Standards Institute (2011) recommendation. REMA has been used for detection of drug resistance in M. tuberculosis. Extended incubation was performed to detect induced resistance. Results: Thirty microliters of resazurin (0.01%) was added after visually taking MIC reading. Resistance was observed in 11.1% of M. bolletti and 4.8% of M. abscessus strains; and induced resistance was detected in 77.8% and 95.2% of M. bolletti and M. abscessus strains, respectively. All strains of M. massiliense were susceptible. The samples presented same MIC value both by visual reading and through resazurin. Conclusion: The present study showed 100% concordance between both readings, with REMA providing easier to read and report results benefit. This change in reading can also reflect on the MIC determination and report, improving the test. J. Clin. Lab. Anal. 30:751-755, 2016. (C) 2016 Wiley Periodicals, Inc.en
dc.description.affiliationAdolfo Lutz Inst, Nucleo TB & Micobacterioses, Sao Paulo, Brazil
dc.description.affiliationUniv Estadual Paulista, Fac Ciencias Farmaceut, Lab Micobacteriol, Araraquara, Brazil
dc.description.affiliationUnespUniv Estadual Paulista, Fac Ciencias Farmaceut, Lab Micobacteriol, Araraquara, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipIdFAPESP: 2013/14957-5
dc.format.extent751-755
dc.identifierhttp://dx.doi.org/10.1002/jcla.21933
dc.identifier.citationJournal Of Clinical Laboratory Analysis. Hoboken: Wiley, v. 30, n. 5, p. 751-755, 2016.
dc.identifier.doi10.1002/jcla.21933
dc.identifier.issn0887-8013
dc.identifier.urihttp://hdl.handle.net/11449/165362
dc.identifier.wosWOS:000386933600064
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofJournal Of Clinical Laboratory Analysis
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectclarithromycin
dc.subjectMycobacterium abscessus
dc.subjectresazurin microtiter assay
dc.subjectsusceptibility testing
dc.titleResazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Groupen
dc.typeArtigopt
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderWiley-Blackwell
dspace.entity.typePublication
relation.isDepartmentOfPublication5004bcab-94af-4939-b980-091ae9d0a19e
relation.isDepartmentOfPublication.latestForDiscovery5004bcab-94af-4939-b980-091ae9d0a19e
unesp.departmentCiências Biológicas - FCFpt

Arquivos